Association Between Polycystic Ovary Syndrome and Cancer Risk
- PMID: 30489606
- PMCID: PMC6439760
- DOI: 10.1001/jamaoncol.2018.5188
Association Between Polycystic Ovary Syndrome and Cancer Risk
Abstract
This cohort study of Swedish register data examines the association between polycystic ovary syndrome and cancer risk in females aged 15 to 50 years between 1985 and 2009.
Conflict of interest statement
Similar articles
-
Polycystic Ovarian Syndrome: Long-Term Health Consequences.Semin Reprod Med. 2017 May;35(3):271-281. doi: 10.1055/s-0037-1603096. Epub 2017 Jun 28. Semin Reprod Med. 2017. PMID: 28658711 Review. No abstract available.
-
Diabetes risk score in the diagnostic categories of polycystic ovary syndrome.Fertil Steril. 2011 Apr;95(5):1742-8. doi: 10.1016/j.fertnstert.2011.01.133. Epub 2011 Feb 12. Fertil Steril. 2011. PMID: 21316662
-
Are expanding disease definitions unnecessarily labelling women with polycystic ovary syndrome?BMJ. 2017 Aug 16;358:j3694. doi: 10.1136/bmj.j3694. BMJ. 2017. PMID: 28814559 No abstract available.
-
Prevalence of the metabolic syndrome in women with a previous diagnosis of polycystic ovary syndrome: long-term follow-up.Fertil Steril. 2011 Nov;96(5):1271-4. doi: 10.1016/j.fertnstert.2011.08.006. Epub 2011 Aug 26. Fertil Steril. 2011. PMID: 21872228
-
Criteria, prevalence, and phenotypes of polycystic ovary syndrome.Fertil Steril. 2016 Jul;106(1):6-15. doi: 10.1016/j.fertnstert.2016.05.003. Epub 2016 May 24. Fertil Steril. 2016. PMID: 27233760 Review.
Cited by
-
Metabolic hormones are integral regulators of female reproductive health and function.Biosci Rep. 2024 Jan 31;44(1):BSR20231916. doi: 10.1042/BSR20231916. Biosci Rep. 2024. PMID: 38131197 Free PMC article. Review.
-
SPIOMET4HEALTH-efficacy, tolerability and safety of lifestyle intervention plus a fixed dose combination of spironolactone, pioglitazone and metformin (SPIOMET) for adolescent girls and young women with polycystic ovary syndrome: study protocol for a multicentre, randomised, double-blind, placebo-controlled, four-arm, parallel-group, phase II clinical trial.Trials. 2023 Sep 15;24(1):589. doi: 10.1186/s13063-023-07593-6. Trials. 2023. PMID: 37715279 Free PMC article.
-
Gut microbiome and reproductive endocrine diseases: a Mendelian randomization study.Front Endocrinol (Lausanne). 2023 Aug 4;14:1164186. doi: 10.3389/fendo.2023.1164186. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37600687 Free PMC article.
-
Obesity, obesity-related metabolic conditions, and risk of thyroid cancer in women: results from a prospective cohort study (Sister Study).Lancet Reg Health Am. 2023 Jun 14;23:100537. doi: 10.1016/j.lana.2023.100537. eCollection 2023 Jul. Lancet Reg Health Am. 2023. PMID: 37346380 Free PMC article.
-
Integrative Analysis of Core Genes and Biological Process Involved in Polycystic Ovary Syndrome.Reprod Sci. 2023 Oct;30(10):3055-3070. doi: 10.1007/s43032-023-01259-z. Epub 2023 May 12. Reprod Sci. 2023. PMID: 37171773
References
-
- Falconer H, Yin L, Bellocco R, Altman D. Thyroid cancer after hysterectomy on benign indications: Findings from an observational cohort study in Sweden. Int J Cancer. 2017;140(8):1796-1801. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
